Biological products, (no diagnostic substances) company · DE · FY ends Dec · -$7M FCF
Revenue declined 100.0% YoY. The question is whether this is cyclical or a structural shift.
Negative free cash flow of -$7M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (FY)
$0.00
▼ -100.0% YoY
Net Income (TTM)
-$8M
▼ -3.5% YoY
Op. Margin
—
ROIC
-422.67%
Cash Flow & Balance Sheet
FCF (TTM)
-$7M
▲ +5.7% YoY
Op. Cash Flow (TTM)
-$7M
▲ +5.7% YoY
Net Debt
-$539K
Net Cash Position
Cash & Equiv.
$951K
Continue Research